In Re Armodafinil Patent Litigation

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel * : Plaintiffs Cephalon, Inc., and Cephalon France have moved, pursuant to 28 U.S.C. § 1407, to centralize this litigation in the District of Delaware. This litigation currently consists of eight actions: seven in the District of Delaware and one in the Southern District of Florida, as listed on Schedule A. Responding defendants Apotex, Inc., and Apotex Corp. (collectively Apotex) oppose centralization.

On the basis of the papers filed and the hearing session held, we find that these eight actions involve common questions of fact, and…